Search results
Results from the WOW.Com Content Network
Haruko Obokata (小保方 晴子, Obokata Haruko, born 1983) is a former stem-cell biologist and research unit leader at Japan's Laboratory for Cellular Reprogramming, Riken Center for Developmental Biology.
Masayo Takahashi (高橋 政代, Takahashi Masayo, born June 23, 1961) is a Japanese medical physician, ophthalmologist and stem cell researcher.. Takahashi serves as a project research leader at the Riken Center for Developmental Biology in Kobe focusing on the clinical application of iPS Cell (induced Pluripotent Stem Cell) technology on macular degeneration.
Yoshiki Sasai (笹井 芳樹, Sasai Yoshiki, 5 March 1962 – 5 August 2014) was a Japanese stem cell biologist.He developed methods to guide human embryonic stem cells (hESCs) into forming brain cortex, eyes (optic cups), and other organs in tissue culture.
This is a list of countries by stem cell research trials for the purpose of commercializing treatments as of June 2020, using data from ClinicalTrials.gov. [ 1 ] Rank
[103] [104] By 2016, research indicated that there were more than 550 stem cell clinics in the US alone selling generally unproven therapies for a wide array of medical conditions in almost every state in the country, [105] altering the dynamic of stem cell tourism. In 2018, the FDA sent a warning letter to StemGenex Biologic Laboratories in ...
On September 12, 2014, surgeons at the Institute of Biomedical Research and Innovation Hospital in Kobe, Japan, transplanted a 1.3 by 3.0 millimeter sheet of retinal pigment epithelium cells, which were differentiated from iPS cells through directed differentiation, into an eye of an elderly woman, who suffers from age-related macular degeneration.
In July 2014, during a scandal involving Japanese stem cell researcher Haruko Obokata fabricating data, doctoring images, and plagiarizing the work of others, Yamanaka faced public scrutiny for his associated work lacking full documentation. Yamanaka denied manipulating images in his papers on embryonic mouse stem cells, but he could not find ...
Stem cell "therapy" is an aspirational goal, is still under development and although there is a great deal of research around the world. [11] Rigorous stem cell trials are still ongoing and patients should be educated to be aware of the unethical clinics in the US or abroad, that offer stem cells procedures as a cure when it is still under ...